KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Jul 26, 2017 $19.15 $19.50 $18.45 $18.80 101 960
Jul 25, 2017 $18.81 $19.15 $18.52 $18.99 249 386
Jul 24, 2017 $17.85 $19.00 $17.85 $18.70 262 990
Jul 21, 2017 $18.20 $18.69 $18.01 $18.01 22 251
Jul 20, 2017 $18.25 $19.50 $18.04 $18.39 41 343
Jul 19, 2017 $17.64 $18.16 $17.64 $18.12 19 820
Jul 18, 2017 $18.00 $18.00 $17.77 $17.80 2 290
Jul 17, 2017 $17.66 $18.33 $17.66 $18.00 22 796
Jul 14, 2017 $18.30 $18.30 $17.58 $17.70 29 884
Jul 13, 2017 $18.71 $19.00 $18.09 $18.47 36 791
Jul 12, 2017 $18.50 $18.70 $18.01 $18.35 27 589
Jul 11, 2017 $18.90 $19.46 $18.69 $18.85 37 842
Jul 10, 2017 $19.54 $19.69 $18.45 $18.90 45 594
Jul 07, 2017 $18.22 $19.44 $17.92 $19.34 32 046
Jul 06, 2017 $18.41 $19.00 $18.41 $18.75 4 115
Jul 05, 2017 $18.48 $19.19 $18.01 $18.50 27 100
Jul 03, 2017 $17.60 $18.90 $17.60 $18.74 34 802
Jun 30, 2017 $18.71 $18.87 $17.56 $18.06 21 447
Jun 29, 2017 $19.33 $19.40 $18.40 $18.88 19 720
Jun 28, 2017 $19.85 $19.85 $19.30 $19.55 8 768
Jun 27, 2017 $19.25 $20.01 $17.26 $19.80 116 871
Jun 26, 2017 $17.41 $19.49 $17.41 $19.43 53 696
Jun 23, 2017 $17.48 $17.88 $15.56 $17.40 13 732
Jun 22, 2017 $17.32 $17.87 $17.21 $17.67 10 187
Jun 21, 2017 $15.81 $17.49 $15.81 $17.45 40 494
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT